Blockchain

The Tie Launches Polkadot Ecosystem Dashboard on The Tie Terminal

Boston, Mass, September 12th, 2024, Chainwire

 

New Dashboard Provides Institutional Clients with In-Depth Insights into the Polkadot Ecosystem

The Tie, a leading provider of market data, news, and analytics for digital assets, launches the Polkadot Ecosystem Dashboard enabling institutional clients to access a comprehensive suite of analytics for Polkadot-based assets.

The Polkadot Ecosystem Dashboard offers a deep dive into essential metrics and insights, enabling users to understand key aspects of the network’s performance and usage. By accessing Polkadot blockchain data via The Tie Terminal, investors and traders can make more informed decisions, enhance their understanding of assets and projects within the ecosystem, and gain valuable insights into one of the most dynamic ecosystems in the digital asset space.

“We’re excited to launch the Polkadot Ecosystem Dashboard, providing our institutional clients with powerful tools to analyze and understand the rapidly evolving Polkadot ecosystem,” said Joshua Frank, Co-Founder & CEO of The Tie. “This addition to The Tie Terminal reflects our commitment to delivering the most comprehensive insights, enabling informed decision-making in institutional crypto.”

The dashboard includes account and native token metrics, allowing users to track the growth of the ecosystem by monitoring new, active, and cumulative account metrics over time for each parachain. This feature provides a clear view of user adoption and engagement, while detailed data on the total, staked, and circulating supply units of parachain tokens reflect community growth and interest. Additionally, information on the number of native token holders and price trends across the ecosystem offers further context for analyzing network performance.

Users can also access an overview of transaction metrics, including the volume of native tokens transferred within parachains over time. Transactions are categorized into signed and unsigned types, providing insights into network activity and user behavior. The dashboard tracks transaction fees in both native tokens and USD and displays transaction counts for parachains with Ethereum Virtual Machine (EVM) compatibility, such as Moonbeam and Astar. Additionally, the dashboard monitors Cross-Consensus Messaging (XCM) transactions, offering a comprehensive understanding of cross-chain interactions and interoperability within the Polkadot network.

The Total Value Locked (TVL) metrics provide a detailed analysis of the value locked across parachains, updated every 12 hours. This includes categories such as staking, governance tokens, and liquid staking. A treemap component offers a visual representation of the latest TVL metrics, presenting a high-level perspective of the ecosystem’s value and activity.

The dashboard also features the latest XCM activity metrics, including data on XCM transfers, messages, open channels, and connected parachains, providing a thorough overview of Polkadot’s cross-chain messaging dynamics. The screener function allows users to track ecosystem coins and events, enabling them to filter the dashboard according to specific coins, watchlists, or sectors. This feature ensures that institutional clients remain updated on critical events within the Polkadot ecosystem, helping them stay ahead of significant developments.

The Polkadot Ecosystem Dashboard is designed to give users a holistic view of the network’s performance, making it easier to track developments, analyze trends, and explore the diverse projects within the Polkadot ecosystem. With this addition, The Tie Terminal continues to be an essential tool for institutional clients seeking comprehensive and actionable data in the digital asset space.

The Polkadot Ecosystem Dashboard is now available under the “Presets” section in the Dashboard Selection screen on The Tie Terminal. For more information, readers can visit The Tie’s website.

About The Tie

The Tie is the leading provider of information services for digital assets operating across three core verticals: Institutional, Data Redistribution, and Corporate Access. On the Institutional side, The Tie’s core offering – The Tie Terminal is the fastest and most comprehensive workstation for institutional digital asset investors. The Tie’s institutional clients include hundreds of the leading traditional and crypto-native hedge funds, VCs, market makers, asset managers, banks, and other institutional market participants.

The Tie’s Redistribution business syndicates data feeds to dozens of leading platforms including FalconX, BitMEX, Real Vision, Broadridge, and Cointelegraph. The Tie’s corporate access business provides direct connectivity between institutions and token issuers through a series of industry leading conferences and events – including our flagship event, The Bridge hosted in 2023 with The New York Stock Exchange.

About Polkadot

Polkadot is the powerful, secure core of Web3, providing a shared foundation that unites some of the world’s most transformative apps and blockchains. Polkadot offers advanced modular architecture that allows devs to easily design and build their own specialized blockchain projects, pooled security that ensures the same high standard for secure block production across all connected chains and apps connected to it, and robust governance that ensures a transparent system where everyone has say in shaping the blockchain ecosystem for growth and sustainability. With Polkadot, users are not just a participant, they are a co-creator with the power to shape its future.

 

Contact

Jonathan Duran
jonathan@distractive.xyz

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

2024-09-17T13:00:00Z

Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform

AMSTERDAM, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RENB) - PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of RenovaroCube’s advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which RenovaroCube is based.

Prof. Mark Hoogendoorn, also a professor of Artificial Intelligence, expressed his enthusiasm: “We were pleased to be engaged to make an assessment of the AI platform; this is exactly the area of PersonalAIze’s expertise.”

Frank van Asch remarked on the collaboration, “The expertise of PersonalAIze’s team is exceptional, and their positive evaluation of our AI/ML platform is invaluable.”

RenovaroCube's AI platform has been advancing innovation for the past 12 years, evolving from its award-winning Fintech roots into a potentially groundbreaking multi-omic molecular differential system that identifies cancer in its earliest stages. It is an open platform that can be used as a SaaS by many private sector and academic or other large hospital and health systems. It is also disease agnostic, so it can be expanded for many purposes.

The initial aim is to transform cancer early detection and early detection of recurrence from a small vial of blood (liquid biopsy), potentially supporting clinicians to initiate treatments as soon as possible towards improved outcomes for patients.

In their analysis, PersonalAIze noted the platform's focus on liquid biopsies and third-generation sequencing coupled with AI techniques as highly promising, potentially allowing for comprehensive analysis across varying cancer types and stages. Prof. Sandjai Bhulai, also a professor of Mathematics, commented on the platform’s unique potential and the impressive multidisciplinary team at RenovaroCube under Frank van Asch’s leadership.

Based on these findings, PersonalAIze is eager to collaborate further with RenovaroCube to enhance and commercialize the platform.

PersonalAIze aims to contribute in several key areas:

  • Advancing AI models by leveraging the latest state-of-the-art techniques.
  • Supporting the professional growth of the software team.
  • Enhancing the explainability of AI models, engaging clinicians in model development.
  • Selecting optimal patient groups for data collection and evaluating models and final products in clinical settings.

This partnership could represent a substantial step forward in the fight against cancer, bringing together AI innovation and healthcare expertise to develop a powerful tool for early detection that has the potential to save countless lives.

About Renovaro
Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.

About PersonalAIze
PersonalAIze focusses on building solutions that improve healthcare by leveraging state-of-the-art AI techniques. It has been founded by four experienced professors bringing together decades of research experience in AI and healthcare with the aim to bring the latest scientific AI developments into healthcare practice faster. PersonalAIze does this through both consultancy and product development and targets clinical decision making systems as well as improvement of health care operations such as capacity planning.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

For media inquiries, please contact: karen@renovarocube.com

Source: Renovaro Inc.


GlobeNewsWire News

Recent Comments